Macías PI, Fernández DND, Castillo GD, Fundora ST

Language: Spanish
References: 12
Page: 381-386
PDF size: 87.35 Kb.

ABSTRACT

Polycythemia vera is a chronic myeloproliferative syndrome resulting from abnormal proliferation of the pluripotent stem cell, giving rise to a clonal hematopoiesis, with predominant erythroid hyperplasia over other hematopoietic lines. In this as in other myeloproliferative syndromes thrombotic and hemorrhagic complications are observed, which are cause of morbidity and mortality in this group of patients. The association of polycythemia vera and thrombophilic states is infrequent and when it appears tendency of thrombus formation is increased. Furthermore, thrombophilias are a heterogeneous group of conditions associated to an increased risk of arterial and venous thrombosis where a group of risk factors exists. We present a 50 year-old male patient with a diagnosis of polycythemia vera 12 years ago, who has been treated with hydroxyurea and recombinant alpha interferon. During the last two years he started suffering recurrent bleeding episodes in both upper and lower limbs also presenting a deep vein thrombosis. Hemostasis studies were performed and a significant reduction in the activity of proteins C and S were detected, which association is infrequently described, concomitant with alterations of platelet function. This case demonstrates the importance of searching for the presence of thrombophilic states associated to hematological malignancies.

REFERENCES

1. Varma S, Sharma A,Malhotra P,Kumari S,Jain S, Varma N. Thrombotic complications of polycythemia vera. Hematology. 2008 Dec;13(6):319-23.

2. García-Conde J, San Miguel JF, Sierra J, Urbano-Ispizua A, Vicente V, Vives Corrons JL. Hematología. Madrid: Aran Ediciones .S.L; 2003.

3. Leiva JC, Pons A, Rencoret G, Aguilera S, Quiroz L, Barrera C, et al. Rol de las trombofilias en infertilidad: ¿Juegan un rol? Rev Med Clin Condes.2010; 21(3):424-31.

4. Zamora-González Y, Agramonte-Llanes O, Gómez-Baute R, Rodríguez-Pérez L. Deficiencia combinada de proteínas C y S. Rev Cubana Hematol Inmunol Hemoter[revista en Internet]. 2013 [citado 2013 Nov 18]; 29(4):[aprox. 0 p.]. Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/76

5. Tang L, Guo T, Yang R, Mei H, Wang H, Lu X, et al. Genetic background analysis of protein C deficiency demonstrates a recurrent mutation associated with venous thrombosis in Chinese Population. PLoS One. 2012; 7(4): e35773. doi: 10.1371/journal.pone.0035773.

6. Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood.2009;114: 937-51.

7. Barbui T, Finazzi G, Falanga Anna. Myeloproliferative neoplasms and thrombosis. Blood.2013;122: 2176-2184.

8. Rubio B, Salazar M, Nava A. Aspectos básicos sobre trombofilia, inflamación y autoinmunidad. El Residente.2012;7:16-20.

9. Barbui T, Carobbio A, Rambaldi A, Finazzi G. Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?. Blood. 2009;114:759-763.

10. Reikvam H, Tiu RV. Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera. Leukemia. 2012;26:563-71.

11. Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Semin Thromb Hemost. 2006; 32(6):589-604.

12. Fernández-Delgado N, Fundora-Sarraff T, Macía-Pérez I. Policitemia Vera. Experiencias en el diagnóstico y tratamiento en el Instituto de Hematología e Inmunología. Rev Cubana Hematol Inmunol Hemoter.2011:27(1)77-90.